{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:28:41Z","timestamp":1791264521387,"version":"4.1.0"},"reference-count":45,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,6,25]],"date-time":"2009-06-25T00:00:00Z","timestamp":1245888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:p><jats:bold>Objective:\u2002<\/jats:bold> To review findings from pharmaco\u2010epidemiological studies exploring antipsychotic (AP) drugs prescribing trends.<\/jats:p><jats:p><jats:bold>Method:\u2002<\/jats:bold> We retrieved original studies that explored AP prescribing trends in general population samples since 2000. For each study, we extracted information on sampling method, period, assessment of AP use and corresponding estimates (incidence rates, prevalence rates, pharmacy sales, prescription data) and diagnostic assessment.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Nearly all studies meeting the inclusion criteria (<jats:italic>n<\/jats:italic>\u2003=\u200317) showed an increase in AP prescriptions, mainly because of a dramatic rise in second\u2010generation antipsychotics (SGAP) prescriptions. APs are often prescribed for non\u2010psychotic disorders in adults as well as in children and adolescents.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Considering the growing number of persons from the general population exposed to APs, population studies assessing the risk\/benefit ratio of SGAP use in disorders other than psychosis are necessary, particularly in children and adolescents.<\/jats:p>","DOI":"10.1111\/j.1600-0447.2009.01425.x","type":"journal-article","created":{"date-parts":[[2009,6,25]],"date-time":"2009-06-25T14:37:28Z","timestamp":1245940648000},"page":"4-10","source":"Crossref","is-referenced-by-count":201,"title":["Antipsychotic prescribing trends: a review of pharmaco\u2010epidemiological studies"],"prefix":"10.1111","volume":"121","author":[{"given":"H.","family":"Verdoux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"B\u00e9gaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,12,14]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.7.526"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.8.1025"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.2.203"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200205000-00008"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7273.1371"},{"key":"e_1_2_9_7_2","first-page":"S112","article-title":"\u2018Schizophrenia and Diabetes 2003\u2019 Expert Consensus Meeting, Dublin, 3\u20134 October 2003: consensus summary","volume":"47","author":"Expert Consensus Meeting","year":"2004","journal-title":"Br J Psychiatry Suppl"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.8.1334"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2008.01208.x"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2008.01158.x"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2008.01204.x"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.703"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0386-1"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1162"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1614.2003.01110.x"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(02)00705-8"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.56.8.904"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/10401230591002084"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ambp.2005.11.002"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.53.4.425"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01905.x"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.6.679"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-004-0868-3"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.158.8.753"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)80050-9"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000157543.74509.c8"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1089\/104454602760386905"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1358"},{"issue":"2","key":"e_1_2_9_29_2","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia. 2nd ed","volume":"161","author":"American\u2010Psychiatric\u2010Association","year":"2004","journal-title":"Am J Psychiatry"},{"key":"e_1_2_9_30_2","volume-title":"Guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia","author":"National Institute for Clinical Excellence","year":"2002"},{"issue":"12","key":"e_1_2_9_31_2","first-page":"1","article-title":"The Expert Consensus Guideline Series. Optimizing pharmacologic treatment of psychotic disorders","volume":"63","author":"Kane J","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbi052"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0608"},{"key":"e_1_2_9_34_2","first-page":"441","article-title":"The latest mania: selling bipolar disorder","volume":"3","author":"Healy D","year":"2006","journal-title":"PLOS Medicine"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.56.5.529"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/gps.871"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-15880"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-977713"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2007.01109.x"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2005.02.001"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.159.4.362"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2005.15.270"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G203"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CHI.0000046842.56865.EC"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CHI.0000046841.56865.37"},{"key":"e_1_2_9_46_2","first-page":"168","article-title":"What\u2019s in a name? The evolution of the nomenclature of antipsychotic drugs","volume":"27","author":"King C","year":"2002","journal-title":"J Psychiatry Neurosci"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.2009.01425.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.2009.01425.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T04:15:45Z","timestamp":1698725745000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.2009.01425.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,14]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1111\/j.1600-0447.2009.01425.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.2009.01425.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,14]]}}}